サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439444

脳波計/EEGシステム - 世界市場の考察、競合情勢、市場予測（2030年）

Electroencephalography Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脳波計/EEGシステム - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脳波計/EEGシステムの市場規模は、2023年に10億5,048万米ドル、2030年までに18億5,084万米ドルに達し、2024年～2030年の予測期間にCAGRで9.96％の成長が見込まれます。脳波計の需要は主に、てんかん、脳卒中、昏睡、睡眠障害などの神経疾患の増加によって後押しされています。さらに、先進の革新的な技術の採用の増加、老年人口の増加、デバイスの発売と承認の増加などが、2024年～2030年の予測期間における市場の全体的な成長に寄与しています。

脳波計/EEGシステムの市場力学

脳波計市場はさまざまな要因によって製品需要の伸びを示しており、主な要因の1つは、てんかん、硬化症、認知症などのさまざまな神経疾患の有病率の増加です。

例えば、世界保健機関（WHO）（2023）によると、世界では毎年推定500万人がてんかんと診断されています。高所得国では、毎年10万人あたり49人がてんかんと診断されています。低中所得国では、この数値は10万人あたり139人にも上ります。そのため、てんかん患者の増加により、大脳皮質と脳深部の構造を記録し、てんかんを診断する脳波計が必要となります。このように、てんかん患者の増加が、予測年における脳波計の需要を増加させます。

さらに、脳卒中は脳への血液供給が減少し、脳組織に酸素や栄養が供給されなくなることで発生します。また、脳に病変のある人は、病変の大きさや場所によって脳波が異常に遅くなることがあります。脳波計は脳虚血に素早く反応し、脳機能の変化を即座に検出します。例えば、World Stroke Organization（2022）によると、世界中で年間1,220万件の脳卒中が新たに発生しており、これは3秒に1件の割合です。また、同資料は4人に1人が一生のうちに脳卒中を発症すると発表しています。したがって、脳卒中患者の増加は、脳波計がそのような神経疾患の診断に役立つことから、脳波計の需要を増加させます。したがって、上記の要因が2024年～2030年の予測期間における脳波計市場の成長に寄与します。

しかし、脳波計に関連する制限や代替のデバイスの存在などが、脳波計市場の成長を抑制する可能性があります。

脳波計/EEGシステム市場のセグメント分析

EEGシステム市場のモダリティセグメントでは、ポータブルデバイスカテゴリが2023年に大きな収益シェアを獲得すると予測されています。これは、このセグメントが提供する利点に起因しています。

例えば、怪我や疾患の後、患者は脳とその活動を継続的にモニタリングする必要があります。そのような場合、脳の生理学的状態を測定するためにポータブル脳波計が推奨されます。

さらに、外傷性脳損傷の症例の増加、製品の発売、承認、合併などがポータブル脳波計の需要を増加させます。例えば、Academy for Multidisciplinary Neurotraumatology（AMN）（2022）によると、世界中で毎年6,400万～7,400万件の外傷性脳損傷（TBI）が新たに発生すると考えられており、結論として、世界中で毎年6,900万人がTBIに苦しんでいます。脳損傷後、脳活動の変化を観察するため、入院中または退院後に脳の継続的なモニタリングが必要となります。このような場合、継続的かつ携帯可能なEEGモニタリングは、早期の神経学的予後予測、可逆的な段階での異常の検出、介入による恩恵の享受、神経学的合併症の予防に役立つ可能性があります。したがって、世界中でTBIの症例数が増加していることから、予測期間に脳波計の需要が増加します。

ポータブル脳波計の製品の発表と承認の増加も、このセグメントの需要にプラスの影響を与える見込みです。例えば、2023年1月、Compumedics LimitedはOktiシステムのFDA承認を取得しました。Oktiシステムは、さまざまな神経疾患の診断、患者ケアの深い理解、また日常的な脳波測定や長期的な脳波測定に向けた使用が想定されています。Oktiはシンプルかつポータブルな無線システムです。無線機能により、医師は患者がベッドを離れている間でも患者の生理学的データをモニターすることができ、重要な臨床イベントを確実に記録することができます。

当レポートでは、世界の脳波計/EEGシステム市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 脳波計/EEGシステム市場レポートのイントロダクション

第2章 脳波計/EEGシステム市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 脳波計/EEGシステム市場の主な要因の分析

  • 脳波計/EEGシステム市場の促進要因
    • 神経疾患の有病率の上昇
    • 脳損傷の増加
    • 脳波計の分野における技術の進歩と研究開発投資の増加
  • 脳波計/EEGシステム市場の抑制要因と課題
    • 脳波計の制限
    • 代替のデバイスの存在
  • 脳波計/EEGシステム市場の機会
    • 脳波計のデジタル化の進行
    • ウェアラブル脳波計の需要の増加

第5章 脳波計/EEGシステム市場のポーターのファイブフォース分析

第6章 脳波計/EEGシステム市場レイアウト

  • タイプ別
    • 脳波計
    • EEGアクセサリ
  • モダリティ別
    • ポータブルデバイス
    • 非ポータブルデバイス
  • 用途別
    • 疾患の診断
    • 麻酔モニタリング
    • 睡眠モニタリング
    • その他
  • エンドユーザー別
    • 病院
    • 在宅医療
    • 診断センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 脳波計/EEGシステム市場の企業と製品のプロファイル

  • Allengers
  • NIHON KOHDEN CORPORATION
  • Cadwell Industries Inc.
  • Magstim EGI
  • Masimo.
  • Natus Medical Incorporated
  • NeuroWave Systems Inc.
  • Seer Medical
  • Ceribell, Inc.
  • Koninklijke Philips N.V.
  • Compumedics
  • NeuroSky
  • Lifelines Neuro
  • Neurosoft
  • BrainScope Company Inc
  • Advanced Brain Monitoring, Inc.
  • EB Neuro S.p.A.
  • g.tec medical engineering GmbH Austria
  • Bitbrain Technologies
  • WAVi

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Electroencephalography Devices/EEG System Market in Global (2021-2030)
  • Table 3: Electroencephalography Devices/EEG System Market in Global by Type (2021-2030)
  • Table 4: Electroencephalography Devices/EEG System Market in Global by Modality (2021-2030)
  • Table 5: Electroencephalography Devices/EEG System Market in Global by Application (2021-2030)
  • Table 6: Electroencephalography Devices/EEG System Market in Global by End-User (2021-2030)
  • Table 7: Electroencephalography Devices/EEG System Market in Global by Geography (2021-2030)
  • Table 8: Electroencephalography Devices/EEG System Market in North America (2021-2030)
  • Table 9: Electroencephalography Devices/EEG System Market in the US (2021-2030)
  • Table 10: Electroencephalography Devices/EEG System Market in Canada (2021-2030)
  • Table 11: Electroencephalography Devices/EEG System Market in Mexico (2021-2030)
  • Table 12: Electroencephalography Devices/EEG System Market in Europe (2021-2030)
  • Table 13: Electroencephalography Devices/EEG System Market in France (2021-2030)
  • Table 14: Electroencephalography Devices/EEG System Market in Germany (2021-2030)
  • Table 15: Electroencephalography Devices/EEG System Market in the United Kingdom (2021-2030)
  • Table 16: Electroencephalography Devices/EEG System Market in Italy (2021-2030)
  • Table 17: Electroencephalography Devices/EEG System Market in Spain (2021-2030)
  • Table 18: Electroencephalography Devices/EEG System Market in the Rest of Europe (2021-2030)
  • Table 19: Electroencephalography Devices/EEG System Market in Asia-Pacific (2021-2030)
  • Table 20: Electroencephalography Devices/EEG System Market in China (2021-2030)
  • Table 21: Electroencephalography Devices/EEG System Market in Japan (2021-2030)
  • Table 22: Electroencephalography Devices/EEG System Market in India (2021-2030)
  • Table 23: Electroencephalography Devices/EEG System Market in Australia (2021-2030)
  • Table 24: Electroencephalography Devices/EEG System Market in South Korea (2021-2030)
  • Table 25: Electroencephalography Devices/EEG System Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Electroencephalography Devices/EEG System Market in the Rest of the World (2021-2030)
  • Table 27: Electroencephalography Devices/EEG System Market in the Middle East (2021-2030)
  • Table 28: Electroencephalography Devices/EEG System Market in Africa (2021-2030)
  • Table 29: Electroencephalography Devices/EEG System Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Electroencephalography Devices/EEG System Market in Global (2021-2030)
  • Figure 3: Electroencephalography Devices/EEG System Market in Global by Type (2021-2030)
  • Figure 4: Electroencephalography Devices/EEG System Market in Global by Modality (2021-2030)
  • Figure 5: Electroencephalography Devices/EEG System Market in Global by Application (2021-2030)
  • Figure 6: Electroencephalography Devices/EEG System Market in Global by End-User (2021-2030)
  • Figure 7: Electroencephalography Devices/EEG System Market in Global by Geography (2021-2030)
  • Figure 8: Electroencephalography Devices/EEG System Market in North America (2021-2030)
  • Figure 9: Electroencephalography Devices/EEG System Market in the US (2021-2030)
  • Figure 10: Electroencephalography Devices/EEG System Market in Canada (2021-2030)
  • Figure 11: Electroencephalography Devices/EEG System Market in Mexico (2021-2030)
  • Figure 12: Electroencephalography Devices/EEG System Market in Europe (2021-2030)
  • Figure 13: Electroencephalography Devices/EEG System Market in France (2021-2030)
  • Figure 14: Electroencephalography Devices/EEG System Market in Germany (2021-2030)
  • Figure 15: Electroencephalography Devices/EEG System Market in the United Kingdom (2021-2030)
  • Figure 16: Electroencephalography Devices/EEG System Market in Italy (2021-2030)
  • Figure 17: Electroencephalography Devices/EEG System Market in Spain (2021-2030)
  • Figure 18: Electroencephalography Devices/EEG System Market in the Rest of Europe (2021-2030)
  • Figure 19: Electroencephalography Devices/EEG System Market in Asia-Pacific (2021-2030)
  • Figure 20: Electroencephalography Devices/EEG System Market in China (2021-2030)
  • Figure 21: Electroencephalography Devices/EEG System Market in Japan (2021-2030)
  • Figure 22: Electroencephalography Devices/EEG System Market in India (2021-2030)
  • Figure 23: Electroencephalography Devices/EEG System Market in Australia (2021-2030)
  • Figure 24: Electroencephalography Devices/EEG System Market in South Korea (2021-2030)
  • Figure 25: Electroencephalography Devices/EEG System Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Electroencephalography Devices/EEG System Market in the Rest of the World (2021-2030)
  • Figure 27: Electroencephalography Devices/EEG System Market in the Middle East (2021-2030)
  • Figure 28: Electroencephalography Devices/EEG System Market in Africa (2021-2030)
  • Figure 29: Electroencephalography Devices/EEG System Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0251

Electroencephalography Devices/EEG System Market By Type (EEG Equipment And EEG Accessories), Modality (Portable Device And Non-Portable Device), By Application (Disease Diagnosis, Anaesthesia Monitoring, Sleep Monitoring, And Others), End-User (Hospitals, Home Healthcare, Diagnostic Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of various neurological diseases and the increasing figures of brain injury across the globe

The global electroencephalography devices or EEG system market was valued at USD 1,050.48 million in 2023, growing at a CAGR of 9.96% during the forecast period from 2024 to 2030 to reach USD 1,850.84 million by 2030. The demand for EEG devices is primarily being boosted by the increasing figures of neurologic disorders such as epilepsy, stroke, coma, sleeping disorders, and others. Further, the rising adoption of advanced and innovative technologies, the increasing geriatric population, the increasing device launches & approval, and others are contributing to the overall growth of the EEG devices market during the forecast period from 2024-2030.

Electroencephalography Devices/EEG System Market Dynamics:

The EEG device market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of various neurological diseases such as epilepsy, sclerosis, dementia, and others.

For instance, according to World Health Organization (WHO) 2023, globally, an estimated 5 million people were diagnosed with epilepsy each year. In high-income countries, 49 per 100,000 people are diagnosed with epilepsy each year. In low- and middle-income countries, this figure can be as high as 139 per 100,000 people. Therefore, the increasing cases of epilepsy will need an EEG device to diagnose epilepsy as the device records activity from the cortex and the deeper brain structures. Thus, the increasing number of cases of epilepsy will increase the demand for EEG devices in the forecast year.

Furthermore, a stroke occurs when the blood supply to the brain is reduced which prevents brain tissue from getting oxygen and nutrients. Also, people with lesions in their brains may have unusually slow EEG waves, depending on the size and the location of the lesion. The EEG devices are rapidly sensitive to brain ischemia and immediately detect changes in brain function. For instance, according to World Stroke Organization 2022, there were 12.2 million new strokes per year around the world which is 1 in every 3 seconds. The same source also stated that 1 in 4 people will have a stroke in their lifetime. Thus, the increasing stroke cases will increase the demand for EEG devices as these devices aid in the diagnosis of such neurological diseases. Therefore, the above-mentioned factors are contributing to the growth of the EEG device market during the forecast period from 2024-2030.

However, the limitation related to EEG devices, the presence of alternative devices, and others may restrict the EEG device market growth.

Electroencephalography Devices/EEG System Market Segment Analysis:

EEG Device Market by Type (EEG Equipment and EEG Accessories), Modality (Portable Device and Non-Portable Device), Application (Disease Diagnosis, Anesthesia Monitoring, Sleep Monitoring, and Others), End-User (Hospitals, Home Healthcare, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the modality segment of the EEG System market, the portable devices category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment.

For instance, after any injury or disease, patients need continuous monitoring of the brain and its activity. In such cases, portable EEG devices are advised to measure the physiological condition of the brain.

Further, the increasing cases of traumatic brain injury, product launches, approval, mergers, and others will increase the demand for portable EEG devices. For instance, according to Academy for Multidisciplinary Neurotraumatology (AMN) 2022, it is considered that somewhere around 64 to 74 million new cases of Traumatic brain injury (TBI) occur annually worldwide, in conclusion, 69 million people worldwide suffer a TBI each year. After the brain injury, a person needs continuous monitoring of the brain either in hospital or after hospital discharge, to observe any changes in the brain activity. In such cases, continuous and portable EEG monitoring may help in early neurological prognostication, to detect abnormalities at a reversible stage, to access the benefits of interventions, and to prevent neurological complications. Thus, the increasing number of cases of TBI worldwide will increase the demand for EEG devices during the forecast period.

The increasing product launches and approval for portable EEG devices will also create a positive impact on the demand of this segment. For instance, in January 2023, Compumedics Limited received FDA approval for the OKTI system. The Okti System is intended for use in the diagnosis of various neurological disorders, a deep understanding of patient care, and also be used for routine and long Term EEG. The Okti is a simple, portable, wireless system. The wireless capability gives physicians the option of monitoring a patient's physiological data while the patients are out of bed, helping to ensure they capture critical clinical events on the recording.

Therefore, owing to the advantages offered by portable devices will increase the demand for portable EEG devices thereby, driving the growth of the EEG device market during the forecast period.

North America is expected to dominate the overall Electroencephalography Devices/EEG System Market:

Among all the regions, North America is estimated to account for the largest share of the EEG device market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of sleep disorders, the growing cases of Alzheimer's disease, the increasing cases of road accidents, and others are driving the North America EEG device market. Furthermore, the increasing geriatric population, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices will also help in the market growth in this region.

The aging population creates an increase in health-related issues, especially in neurological diseases due to the physiological changes that can cause glitches in brain functions, as the hormones and proteins decline with age. Older people often experience decreased blood flow to the brain, which can impair memory and can lead to changes in cognitive skills. Therefore, to prevent any future complications older people need continuous monitoring of the brain, which can be provided by an EEG device. For instance, according to the Centers for Disease and Prevention Control (CDC) 2022, by 2040, the number of older adults in the United States is expected to reach 80.8 million. By 2060, it will reach 94.7 million, and older adults will make up nearly 25% of the US population. Thus, the increasing geriatric population in the US will increase the demand for EEG devices as elderly patients may need to use EEG devices for continued monitoring of the brain's activity which can help to diagnose any chronic changes in the brain and to prevent stroke or other life-threatening conditions. Thus, the increasing geriatric population in North America will increase the demand for EEG devices during the forecast period.

Further, in sleep apnea the extracted signals from EEG allow a person to monitor brain activities and diagnose sleep disorders such as insomnia, narcolepsy-cataplexy syndrome, and obstructive sleep apnoea syndrome. For instance, as per the CDC 2022, in 2020, 14.5% of adults had trouble falling asleep most days or every day in the past 30 days in the US. As per the same source, a greater percentage of non-Hispanic White (21.0%) adults had trouble staying asleep most days or every day compared with non-Hispanic Black (15.4%), Hispanic (10.6%), and non-Hispanic Asian (8.7%) adults. Younger adults were less likely to have trouble staying asleep (13.8%) of those aged 18-44) compared with adults aged 45-64 (21.8%). Thus, the increasing population of sleep apnea will increase the demand for EEG devices as these devices are used for continuous monitoring of brain activity and sleeping obstruction.

Coupled with the factors mentioned above, strategic activities such as product launches & approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in August 20221 Ceribell, Inc. received FDA approval for Ceribell Instant EEG Headband. The Ceribell Instant EEG Headband is an electroencephalogram (EEG) electrode array intended for single-patient use, it records EEG in patients of 2 years and older. The instant EEG headband is intended for prescription use in the home, healthcare facility, or clinical research environment. Thus, such strategic steps help to increase the demand for EEG devices, thereby driving the North America EEG device market forward during the forecast period.

Electroencephalography Devices/EEG System Market Key Players:

Some of the key market players operating in the EEG devices market include Allengers, Nihon kohden corporation, cadwell industries, magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others.

Recent Developmental Activities in the Electroencephalography Devices/EEG System Market:

In January 2023, Bioserenity received FDA approval for Neuronaute with IceCap 2 & IceCap 2 Small. Neuronaute with IceCap2 & IceCap 2 Small, is a system intended to acquire, display, store, archive, and periodically transmit EEG signals from the brain using a full montage array to enable review at a physician's office, hospital, or other remote locations.

In December 2022, Natus Medical completed the previously announced acquisition with Micromed Holdings. Natus Neuro Team will work closely with Micromed management to build upon the Micromed momentum in the European epilepsy market and the emerging presence of Moberg in the ICU.

In December 2021, WAVi Co. received FDA approval for WAVi SCAN EEG System and Accessories. WAVi SCAN is intended for the acquisition, display, and storage, of electrical activity of a patient's brain including electroencephalograph (EEG) and event-related potentials (ERP) obtained by placing two or more electrodes on the head to aid in diagnosis.

In July 2021, Seer medical pty ltd. received FDA approval for Seer Home EEG device. The EEG system Seer Home is intended to acquire, display, and store the electro-physiological signals of the patient's brain obtained by placing electrodes on the patient's scalp.

Key Takeaways from the Electroencephalography Devices/EEG System Market Report Study

Market size analysis for current EEG device market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the EEG device market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global EEG device market.

Various opportunities available for the other competitor in the EEG device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current EEG device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for EEG device market growth in the coming future?

Target Audience who can be benefited from this Electroencephalography Devices/Eeg System Market Report Study

EEG device products providers

Research organizations and consulting companies

EEG device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in EEG device

Various End-users who want to know more about the EEG device market and the latest technological developments in the EEG device market.

Frequently Asked Questions For the Electroencephalography Devices/Eeg System Market:

1. What are electroencephalography devices/EEG systems?

Electroencephalography (EEG) devices, is a medical device that detects abnormalities in brain waves, or the electrical activity in the brain that might be useful in diagnosing various brain disorders, such as epilepsy or seizure.

The device can also help diagnose dementia, sleep disorder, Alzheimer's disease, brain tumors, encephalitis, and others.

2. What is the market for global electroencephalography devices/EEG systems?

The global electroencephalography devices or EEG system market was valued at USD 1,050.48 million in 2023, growing at a CAGR of 9.96% during the forecast period from 2024 to 2030 to reach USD 1,850.84 million by 2030.

3. What are the drivers for the global electroencephalography devices/EEG system market?

The demand for EEG devices is primarily being heightened by the increasing prevalence of neurological diseases such as epilepsy, stroke, Alzheimer's disease, and others. In addition, the advancement in EEG devices, the increasing number of traumatic brain injuries, the rising geriatric population prone to neurological disorders, the increasing device launches & approvals, and others contribute to the overall growth of the EEG device market during the forecast period from 2024-2030.

4. Who are the key players operating in the global electroencephalography devices/EEG system market?

Some of the key market players operating in the EEG device market include Allengers, Nihon kohden corporation, cadwell industries, magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others.

5. Which region has the highest share in the electroencephalography devices/EEG system market?

North America is expected to dominate the overall EEG device market during the forecast period from 2024-2030. Factors such as the rising prevalence of sleep disorders, the growing cases of Alzheimer's disease, the increasing geriatric population, and others will create a positive impact on the North America EEG market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and increasing awareness about regular monitoring of brain activity will also help in the market growth in this region.

Table of Contents

1.Electroencephalography Devices/EEG System Market Report Introduction

2. Electroencephalography Devices/EEG System Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Electroencephalography Devices/EEG System Market Key Factors Analysis

  • 4.1. Electroencephalography Devices/EEG System Market Drivers
    • 4.1.1. Rising prevalence of neurological disorders
    • 4.1.2. Increasing figure of brain injury
    • 4.1.3. Technological advancement in the field of EEG equipment and increasing investment in R&D
  • 4.2. Electroencephalography Devices/EEG System Market Restraints and Challenges
    • 4.2.1. Limitations of EEG devices
    • 4.2.2. Presence of alternative devices
  • 4.3. Electroencephalography Devices/EEG System Market Opportunities
    • 4.3.1. Growing digitalization in EEG devices
    • 4.3.2. Increasing demand for wearable EEG devices

5. Electroencephalography Devices/EEG System Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Electroencephalography Devices/EEG System Market Layout

  • 6.1. By Type
    • 6.1.1. EEG equipment
    • 6.1.2. EEG accessories
  • 6.2. By Modality
    • 6.2.1. Portable Device
    • 6.2.2. Non-Portable Device
  • 6.3. By Application
    • 6.3.1. Disease Diagnosis
    • 6.3.2. Anesthesia Monitoring
    • 6.3.3. Sleep Monitoring
    • 6.3.4. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Home Healthcare
    • 6.4.3. Diagnostic Centers
    • 6.4.4. Others
  • 6.5. By Geography
    • 6.5.1. North America
      • 6.5.1.1. United States Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.1.2. Canada Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.2. Europe
      • 6.5.2.1. France Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific
      • 6.5.3.1. China Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.3.3. India Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW)
      • 6.5.4.1. Middle East Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)

7. Electroencephalography Devices/EEG System Market Company and Product Profiles

  • 7.1. Allengers
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. NIHON KOHDEN CORPORATION
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Cadwell Industries Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Magstim EGI
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Masimo.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Natus Medical Incorporated
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. NeuroWave Systems Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Seer Medical
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Ceribell, Inc.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Koninklijke Philips N.V.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Compumedics
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. NeuroSky
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Lifelines Neuro
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Neurosoft
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. BrainScope Company Inc
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Advanced Brain Monitoring, Inc.
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. EB Neuro S.p.A.
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. g.tec medical engineering GmbH Austria
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Bitbrain Technologies
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. WAVi
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us